Mark P. Joing
Finanzdirektor/CFO bei SANY HEAL
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Sandra Shpilberg | F | 48 |
Nora Therapeutics, Inc.
 Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | 5 Jahre |
| Elisabeth Sandoval | F | 62 | 5 Jahre | |
| Anthony Japour | M | 64 | - | |
| Barbara Nelsen | F | 62 | - | |
| Timothy Zanni | M | 63 | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ted Love | M | 65 |
Nuvelo, Inc.
| 8 Jahre |
| Gary Titus | M | 64 |
Nuvelo, Inc.
| 3 Jahre |
| Elias Bendekgey | M | 66 |
Nuvelo, Inc.
| 5 Jahre |
| Jan Johansson | M | - |
Nuvelo, Inc.
| 1 Jahre |
| Kim Popovits | F | 65 |
Nuvelo, Inc.
| 4 Jahre |
| Paul S. Kwon | M | 53 |
Nora Therapeutics, Inc.
Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | 5 Jahre |
| Kirk James Hayenga | M | - |
Nuvelo, Inc.
| 6 Jahre |
| Shelly Guyer | F | 63 |
Nuvelo, Inc.
| 1 Jahre |
| S. Michael Imperiale | M | - |
Nuvelo, Inc.
| 3 Jahre |
| Luis Peña | M | 61 |
Nuvelo, Inc.
| 4 Jahre |
| Jill M. Pergande | F | - |
Nuvelo, Inc.
| 3 Jahre |
| Gregory S. Yedinak | M | - |
Nuvelo, Inc.
| 3 Jahre |
| Steven R. Deitcher | M | 59 |
Nuvelo, Inc.
| 3 Jahre |
| Simon Allen | M | 56 |
Nuvelo, Inc.
| 2 Jahre |
| Linda Fitzpatrick | F | 67 |
Nuvelo, Inc.
| 4 Jahre |
| James R. Gavin | M | 78 |
Nuvelo, Inc.
| 3 Jahre |
| Barry Zubrow | M | 70 |
Nuvelo, Inc.
| 3 Jahre |
| Michael D. Levy | M | 63 |
Nuvelo, Inc.
| 4 Jahre |
| Martin Vogelbaum | M | 60 |
Nuvelo, Inc.
| 8 Jahre |
| Peter García | M | 62 |
Nuvelo, Inc.
| 3 Jahre |
| Thomas N. McCarter | M | 93 |
Nuvelo, Inc.
| 8 Jahre |
| Dennis Fenton | M | 72 |
Nora Therapeutics, Inc.
Nora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Nora Therapeutics, Inc. develops therapeutics to address clinical unmet needs in reproductive medicine. Its's lead product NT100, seeks to improve pregnancy outcomes in women undergoing in vitro fertilization or who have suffered recurrent spontaneous miscarriages. The company was founded by Darryl L. Carter and Chris B. McClain in 2007 and is headquartered in Palo Alto, CA. | - |
| Burton E. Sobel | M | 86 |
Nuvelo, Inc.
| 5 Jahre |
| Henry Ward Wolff | M | 75 |
Nuvelo, Inc.
| 1 Jahre |
| George B. Rathmann | M | - |
Nuvelo, Inc.
| 6 Jahre |
| Raymond Steitz | M | - | 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 31 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Mark P. Joing
- Persönliches Netzwerk